Siva S Panda

ResearcherID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 44

Top Venues

Molecules (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

RSC advances

Chemical communications (Cambridge, England)

Augusta University

University of Delhi (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Augusta University Aug 10 2015

United States

Assistant Professor :: Chemistry & Physics

Sigma Aldrich Co Jan 01 2015 - Aug 07 2015

United States

Sr. Production Scientist :: R&D

University of Florida Feb 15 2014 - Dec 31 2014

United States

Postdoctoral Research Associate :: Medicine

University of Florida May 14 2010 - Feb 14 2014

United States

Postdoctoral Associate :: Chemistry

Dabur Research Foundation Jul 01 2005 - Jan 31 2006

India

Research Associate :: R&D

Education History

University of Delhi Jan 09 2006 - May 11 2010

India

PHD :: Chemistry

Publications

Kunj Bihari Gupta, Truett L Taylor, Siva S Panda, Muthusamy Thangaraju, Vinata B Lokeshwar
Curcumin-Dichloroacetate Hybrid Molecule as an Antitumor Oral Drug against Multidrug-Resistant Advanced Bladder Cancers. Cancers 16 (17) (2024)
Juliette R Seremak, Kunj Bihari Gupta, Sunilkanth Bonigala, Elise Liu, Brendan Marshall, Wenbo Zhi, Riham M Bokhtia, Siva S Panda, Vinata B Lokeshwar, Vinata B Lokeshwar
Targeting Chemoresistance in Advanced Bladder Cancers with a Novel Adjuvant Strategy. Molecular cancer therapeutics (2024)
Narendra Dinkar Kharat, Sushma Naharwal, Siva S Panda, Kiran Bajaj, Rajeev Sakhuja
Iridium-catalyzed diacylmethylation of tyrosine and its peptides with sulfoxonium ylides. Chemical communications (Cambridge, England) 60 (59) (2024)
Sara M Hassan, Alyaa Farid, Siva S Panda, Mohamed S Bekheit, Holden Dinkins, Walid Fayad, Adel S Girgis
Indole Compounds in Oncology: Therapeutic Potential and Mechanistic Insights. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Sara M Hassan, Alyaa Farid, Siva S Panda, Mohamed S Bekheit, Holden Dinkins, Walid Fayad, Adel S Girgis
Indole Compounds in Oncology: Therapeutic Potential and Mechanistic Insights. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Juliette R Seremak, Kunj Bihari Gupta, Sunilkanth Bonigala, Elise Liu, Brendan Marshall, Wenbo Zhi, Riham M Bokhtia, Siva S Panda, Vinata B Lokeshwar, Vinata B Lokeshwar
Targeting Chemoresistance in Advanced Bladder Cancers with a Novel Adjuvant Strategy. Molecular cancer therapeutics (2024)
Sara M Hassan, Alyaa Farid, Siva S Panda, Mohamed S Bekheit, Holden Dinkins, Walid Fayad, Adel S Girgis
Indole Compounds in Oncology: Therapeutic Potential and Mechanistic Insights. Pharmaceuticals (Basel, Switzerland) 17 (7) (2024)
Narendra Dinkar Kharat, Sushma Naharwal, Siva S Panda, Kiran Bajaj, Rajeev Sakhuja
Iridium-catalyzed diacylmethylation of tyrosine and its peptides with sulfoxonium ylides. Chemical communications (Cambridge, England) (2024)
Devan Buchanan, Ashley M Pham, Sandeep K Singh, Siva S Panda
Molecular Hybridization of Alkaloids Using 1,2,3-Triazole-Based Click Chemistry. Molecules (Basel, Switzerland) 28 (22) (2023)
Riham M Bokhtia, Siva S Panda, Adel S Girgis, Nermin Samir, Mona F Said, Anwar Abdelnaser, Soad Nasr, Mohamed S Bekheit, Abdelhameed S Dawood, Horrick Sharma, Margaret Wade, Swapnil K Sharma, Amany M Ghanim
New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation. Molecules (Basel, Switzerland) 28 (4) (2023)
Siva S Panda, Marian N Aziz, Jacek Stawinski, Adel S Girgis
Azomethine Ylides-Versatile Synthons for Pyrrolidinyl-Heterocyclic Compounds. Molecules (Basel, Switzerland) 28 (2) (2023)
Riham M Bokhtia, Siva S Panda, Adel S Girgis, Nermin Samir, Mona F Said, Anwar Abdelnaser, Soad Nasr, Mohamed S Bekheit, Abdelhameed S Dawood, Horrick Sharma, Margaret Wade, Swapnil K Sharma, Amany M Ghanim
New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation. Molecules (Basel, Switzerland) 28 (4) (2023)
Riham M Bokhtia, Siva S Panda, Adel S Girgis, Nermin Samir, Mona F Said, Anwar Abdelnaser, Soad Nasr, Mohamed S Bekheit, Abdelhameed S Dawood, Horrick Sharma, Margaret Wade, Swapnil K Sharma, Amany M Ghanim
New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation. Molecules (Basel, Switzerland) 28 (4) (2023)
Riham M Bokhtia, Siva S Panda, Adel S Girgis, Nermin Samir, Mona F Said, Anwar Abdelnaser, Soad Nasr, Mohamed S Bekheit, Abdelhameed S Dawood, Horrick Sharma, Margaret Wade, Swapnil K Sharma, Amany M Ghanim
New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation. Molecules (Basel, Switzerland) 28 (4) (2023)
Riham M Bokhtia, Siva S Panda, Adel S Girgis, Nermin Samir, Mona F Said, Anwar Abdelnaser, Soad Nasr, Mohamed S Bekheit, Abdelhameed S Dawood, Horrick Sharma, Margaret Wade, Swapnil K Sharma, Amany M Ghanim
New NSAID Conjugates as Potent and Selective COX-2 Inhibitors: Synthesis, Molecular Modeling and Biological Investigation. Molecules (Basel, Switzerland) 28 (4) (2023)
Siva S Panda, Adel S Girgis, Marian N Aziz, Mohamed S Bekheit
Spirooxindole: A Versatile Biologically Active Heterocyclic Scaffold. Molecules (Basel, Switzerland) 28 (2) (2023)
Siva S Panda, Marian N Aziz, Jacek Stawinski, Adel S Girgis
Azomethine Ylides-Versatile Synthons for Pyrrolidinyl-Heterocyclic Compounds. Molecules (Basel, Switzerland) 28 (2) (2023)
Siva S Panda, Marian N Aziz, Jacek Stawinski, Adel S Girgis
Azomethine Ylides-Versatile Synthons for Pyrrolidinyl-Heterocyclic Compounds. Molecules (Basel, Switzerland) 28 (2) (2023)
Siva S Panda, Adel S Girgis, Marian N Aziz, Mohamed S Bekheit
Spirooxindole: A Versatile Biologically Active Heterocyclic Scaffold. Molecules (Basel, Switzerland) 28 (2) (2023)
Siva S Panda, Marian N Aziz, Jacek Stawinski, Adel S Girgis
Azomethine Ylides-Versatile Synthons for Pyrrolidinyl-Heterocyclic Compounds. Molecules (Basel, Switzerland) 28 (2) (2023)
Siva S Panda, Adel S Girgis, Marian N Aziz, Mohamed S Bekheit
Spirooxindole: A Versatile Biologically Active Heterocyclic Scaffold. Molecules (Basel, Switzerland) 28 (2) (2023)
Siva S Panda, Muthusamy Thangaraju, Vinata B Lokeshwar
Ursolic Acid Analogs as Potential Therapeutics for Cancer. Molecules (Basel, Switzerland) 27 (24) (2022)
Abigail L Flint, David W Hansen, LaVauria D Brown, Laura E Stewart, Eduardo Ortiz, Siva S Panda
Modified Curcumins as Potential Drug Candidates for Breast Cancer: An Overview. Molecules (Basel, Switzerland) 27 (24) (2022)
Siva S Panda, Muthusamy Thangaraju, Vinata B Lokeshwar
Ursolic Acid Analogs as Potential Therapeutics for Cancer. Molecules (Basel, Switzerland) 27 (24) (2022)
Kailey A Wyman, Adel S Girgis, Pragnakiran S Surapaneni, Jade M Moore, Noura M Abo Shama, Sara H Mahmoud, Ahmed Mostafa, Reham F Barghash, Zou Juan, Radha D Dobaria, Ahmad J Almalki, Tarek S Ibrahim, Siva S Panda
Synthesis of Potential Antiviral Agents for SARS-CoV-2 Using Molecular Hybridization Approach. Molecules (Basel, Switzerland) 27 (18) (2022)
Abigail L Flint, David W Hansen, LaVauria D Brown, Laura E Stewart, Eduardo Ortiz, Siva S Panda
Modified Curcumins as Potential Drug Candidates for Breast Cancer: An Overview. Molecules (Basel, Switzerland) 27 (24) (2022)
Israa A Seliem, Siva S Panda, Adel S Girgis, Queen L Tran, Mona F Said, Mohamed S Bekheit, Anwar Abdelnaser, Soad Nasr, Walid Fayad, Ahmed A F Soliman, Rajeev Sakhuja, Tarek S Ibrahim, Zakaria K M Abdel-Samii, Amany M M Al-Mahmoudy
Development of Isatin-Based Schiff Bases Targeting VEGFR-2 Inhibition: Synthesis, Characterization, Antiproliferative Properties, and QSAR Studies. ChemMedChem 17 (13) (2022)
Siva S Panda, Muthusamy Thangaraju, Vinata B Lokeshwar
Ursolic Acid Analogs as Potential Therapeutics for Cancer. Molecules (Basel, Switzerland) 27 (24) (2022)
Abigail L Flint, David W Hansen, LaVauria D Brown, Laura E Stewart, Eduardo Ortiz, Siva S Panda
Modified Curcumins as Potential Drug Candidates for Breast Cancer: An Overview. Molecules (Basel, Switzerland) 27 (24) (2022)
Siva S Panda, Muthusamy Thangaraju, Vinata B Lokeshwar
Ursolic Acid Analogs as Potential Therapeutics for Cancer. Molecules (Basel, Switzerland) 27 (24) (2022)
Riham M Bokhtia, Adel S Girgis, Tarek S Ibrahim, Fatma Rasslan, Eman S Nossier, Reham F Barghash, Rajeev Sakhuja, Eatedal H Abdel-Aal, Siva S Panda, Amany M M Al-Mahmoudy
Synthesis, Antibacterial Evaluation, and Computational Studies of a Diverse Set of Linezolid Conjugates. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Siva S Panda, Muthusamy Thangaraju, Vinata B Lokeshwar
Ursolic Acid Analogs as Potential Therapeutics for Cancer. Molecules (Basel, Switzerland) 27 (24) (2022)
Abigail L Flint, David W Hansen, LaVauria D Brown, Laura E Stewart, Eduardo Ortiz, Siva S Panda
Modified Curcumins as Potential Drug Candidates for Breast Cancer: An Overview. Molecules (Basel, Switzerland) 27 (24) (2022)
Siva S Panda, Queen L Tran, Pragya Rajpurohit, Girinath G Pillai, Sean J Thomas, Allison E Bridges, Jason E Capito, Muthusamy Thangaraju, Vinata B Lokeshwar
Design, Synthesis, and Molecular Docking Studies of Curcumin Hybrid Conjugates as Potential Therapeutics for Breast Cancer. Pharmaceuticals (Basel, Switzerland) 15 (4) (2022)
Abigail L Flint, David W Hansen, LaVauria D Brown, Laura E Stewart, Eduardo Ortiz, Siva S Panda
Modified Curcumins as Potential Drug Candidates for Breast Cancer: An Overview. Molecules (Basel, Switzerland) 27 (24) (2022)
Francesca Curreli, Shahad Ahmed, Sofia M B Victor, Aleksandra Drelich, Siva S Panda, Andrea Altieri, Alexander V Kurkin, Chien-Te K Tseng, Christopher D Hillyer, Asim K Debnath
Discovery of Highly Potent Fusion Inhibitors with Potential Pan-Coronavirus Activity That Effectively Inhibit Major COVID-19 Variants of Concern (VOCs) in Pseudovirus-Based Assays. Viruses 14 (1) (2021)
Eyana Thomas, Laura E Stewart, Brien A Darley, Ashley M Pham, Isabella Esteban, Siva S Panda
Plant-Based Natural Products and Extracts: Potential Source to Develop New Antiviral Drug Candidates. Molecules (Basel, Switzerland) 26 (20) (2021)
M Adel Youssef, Siva S Panda, Riham A El-Shiekh, ElSayed M Shalaby, Dalia R Aboshouk, Walid Fayad, Nehmedo G Fawzy, Adel S Girgis
Synthesis and molecular modeling studies of cholinesterase inhibitor dispiro[indoline-3,2'-pyrrolidine-3',3''-pyrrolidines]. RSC advances 10 (37) (2020)
Tarek S Ibrahim, Ehab S Taher, Ebtihal Samir, Azizah M Malebari, Ahdab N Khayyat, Mamdouh F A Mohamed, Riham M Bokhtia, Mohammed A AlAwadh, Israa A Seliem, Hani Z Asfour, Nabil Abdulhafiz Alhakamy, Siva S Panda, Amany M M Al-Mahmoudy
In Vitro Antimycobacterial Activity and Physicochemical Characterization of Diaryl Ether Triclosan Analogues as Potential InhA Reductase Inhibitors. Molecules (Basel, Switzerland) 25 (14) (2020)
Siva S Panda, Adel S Girgis, Hitesh H Honkanadavar, Riham F George, Aladdin M Srour
Synthesis of new ibuprofen hybrid conjugates as potential anti-inflammatory and analgesic agents. Future medicinal chemistry 12 (15) (2020)
Siva S Panda, Adel S Girgis, Bibhuti B Mishra, Mohamed Elagawany, Venkatasai Devarapalli, William F Littlefield, Ahmed Samir, Walid Fayad, Nehmedo G Fawzy, Aladdin M Srour, Riham M Bokhtia
Synthesis, computational studies, antimycobacterial and antibacterial properties of pyrazinoic acid-isoniazid hybrid conjugates. RSC advances 9 (35) (2019)
Nehmedo G Fawzy, Siva S Panda, Walid Fayad, ElSayed M Shalaby, Aladdin M Srour, Adel S Girgis
Synthesis, human topoisomerase IIα inhibitory properties and molecular modeling studies of anti-proliferative curcumin mimics. RSC advances 9 (58) (2019)
Israa A Seliem, Siva S Panda, Adel S Girgis, Yosra I Nagy, Riham F George, Walid Fayad, Nehmedo G Fawzy, Tarek S Ibrahim, Amany M M Al-Mahmoudy, Rajeev Sakhuja, Zakaria K M Abdel-Samii
Design, synthesis, antimicrobial, and DNA gyrase inhibitory properties of fluoroquinolone-dichloroacetic acid hybrids. Chemical biology & drug design 95 (2) (2019)
Marian N Aziz, Siva S Panda, ElSayed M Shalaby, Nehmedo G Fawzy, Adel S Girgis
Facile synthetic approach towards vasorelaxant active 4-hydroxyquinazoline-4-carboxamides. RSC advances 9 (49) (2019)

Siva S Panda.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Siva S Panda